临床和实验室研究年鉴

  • 国际标准期刊号: 2386-5180
  • 期刊 h 指数: 17
  • 期刊引用分数: 6.26
  • 期刊影响因子: 5.31
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 研究期刊索引目录 (DRJI)
  • 普布隆斯
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
分享此页面

抽象的

Validation of the Reagent Hormone AntiMullerian Plus (Roche Diagnostics) for the Dosage of FSH Recombinant Delta (Ferring Pharmaceuticals) in Patients Submitted to Techniques of Assisted Reproduction

Maria De Las Mercedes Calero Ruiz, Marta Rico Rodriguez, Olga Diz Mellado, Ana Isabel Mangano Armada, Maria Angeles Bailén Garcia and Rafael Torrejon Cardoso

Ovarian stimulation is one of the fundamental pillars on which the treatment of in vitro fertilization is based The biopharmaceutical company Ferring has proposed the posology of recombinant FSH in an individualized manner according to the levels of anti-Mulleriana hormone in blood and body weight